findmyKOL
Clinical trialNCT06656416RecruitingPhase 2Interventional

ALTO-100 in Bipolar Disorder With Depression (BD-D)

SponsorAlto NeuroscienceEnrollment200Bipolar Disorder I or II With a Major Depressive Episode
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Site 6036

    Chandler, Arizona, United States

    Withdrawn
  • Site 6000

    Phoenix, Arizona, United States

    Recruiting
  • Site 6087

    Yuma, Arizona, United States

    Recruiting
  • 6039

    Fayetteville, Arkansas, United States

    Recruiting
  • 6070

    Little Rock, Arkansas, United States

    Recruiting
  • Site 6081

    Imperial, California, United States

    Recruiting
  • 6069

    Los Angeles, California, United States

    Recruiting
  • Site 6016

    Mather, California, United States

    Not, yet, recruiting
  • Site 6082

    Oceanside, California, United States

    Recruiting
  • Site 6102

    Riverside, California, United States

    Recruiting
  • Site 6112

    Colorado Springs, Colorado, United States

    Not, yet, recruiting
  • Site 6067

    Lauderhill, Florida, United States

    Withdrawn
  • Site 6068

    Atlanta, Georgia, United States

    Recruiting
  • Site 6064

    Peachtree Corners, Georgia, United States

    Recruiting
  • Site 6151

    Baltimore, Maryland, United States

    Withdrawn
  • Site 6076

    Bel Air, Maryland, United States

    Recruiting
  • Site 6062

    Gaithersburg, Maryland, United States

    Recruiting
  • Site 6142

    Lincoln, Nebraska, United States

    Recruiting
  • Site 6104

    Las Vegas, Nevada, United States

    Recruiting
  • Site 6144

    Las Vegas, Nevada, United States

    Recruiting
  • Site 6066

    Toms River, New Jersey, United States

    Recruiting
  • Site 6014

    Albuquerque, New Mexico, United States

    Not, yet, recruiting
  • Site 6078

    Albuquerque, New Mexico, United States

    Recruiting
  • 6065

    North Canton, Ohio, United States

    Recruiting
  • Site 6075

    Westlake, Ohio, United States

    Recruiting
  • Site 6072

    Houston, Texas, United States

    Recruiting
  • Site 6121

    Draper, Utah, United States

    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Oct 2024
Primary completion
31 Aug 2026
Completion
31 Oct 2026
Last update posted
16 Jul 2025
Registered enrollment
200
Registry id
NCT06656416

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.